» Articles » PMID: 38321808

MicroRNAs Are Associated with Cardiac Biomarkers, Cardiac Structure and Function and Incident Outcomes in Heart Failure

Overview
Journal ESC Heart Fail
Date 2024 Feb 7
PMID 38321808
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The association between microRNAs (miRNAs) and established cardiac biomarkers is largely unknown. We aimed to measure the association between plasma miRNAs and N-terminal pro-B-type natriuretic peptide (NT-proBNP), cardiac troponin I, soluble urokinase-type plasminogen activator receptor (suPAR), and galectin-3 with cardiac structure and function and clinical outcomes.

Methods And Results: We quantified 32 plasma miRNAs using the FirePlex miRNA assay and measured biomarkers in 139 individuals with symptomatic heart failure (HF). We used principal component (PC) analysis and linear regression to evaluate the association between miRNAs and biomarkers with ventricular size and function by echocardiography and Cox modelling for the incidence of a first composite event of HF hospitalization, heart transplant, left ventricular assist device implant, or death. The mean (standard deviation) age at baseline was 64.3 (12.4) years, 33 (24%) were female, and 122 (88%) were White. A total of 45 events occurred over a median follow-up of 368 (interquartile range 234, 494) days. Baseline NT-proBNP (β = -2.0; P = 0.001) and miRNA PC2 (β = 2.6; P = 0.002) were associated with baseline left ventricular ejection fraction. NT-proBNP (β = 20.6; P = 0.0004), suPAR (β = -39.6; P = 0.005), and PC4 (β = 21.1; P = 0.02) were associated with baseline left ventricular end-diastolic volumes. NT-proBNP [hazard ratio (HR) 1.67, 95% confidence interval (CI) 1.28-2.18, P = 0.0002], galectin-3 (HR 2.02, 95% CI 1.05-3.91, P = 0.036), PC3 (HR 1.75, 95% CI 1.23-2.49, P = 0.002), and PC4 (HR 1.67, 95% CI 1.1-2.52, P = 0.016) were independently associated with incident events.

Conclusions: Biomarkers and miRNA PCs are associated with cardiac structure and function and incident cardiovascular outcomes. Combining information from miRNAs provides prognostic information beyond biomarkers in HF.

Citing Articles

Association of liver fibrosis scores with all-cause and cardiovascular mortality in patients with heart failure.

Guo Z, Ye Z, Xu Q, Li Y, Zheng J Clin Transl Sci. 2024; 17(12):e70104.

PMID: 39686669 PMC: 11649953. DOI: 10.1111/cts.70104.


Emerging Role of Natriuretic Peptides in Diabetes Care: A Brief Review of Pertinent Recent Literature.

Tiwari D, Aw T Diagnostics (Basel). 2024; 14(19).

PMID: 39410655 PMC: 11476269. DOI: 10.3390/diagnostics14192251.


Understanding Galectin-3's Role in Diastolic Dysfunction: A Contemporary Perspective.

Hao W, Cheng C, Liu J, Chen H, Chen J, Cheng T Life (Basel). 2024; 14(7).

PMID: 39063659 PMC: 11277993. DOI: 10.3390/life14070906.


MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure.

Spahillari A, Jackson L, Varrias D, Michelhaugh S, Januzzi J, Shahideh B ESC Heart Fail. 2024; 11(3):1400-1410.

PMID: 38321808 PMC: 11098646. DOI: 10.1002/ehf2.14649.

References
1.
Spahillari A, Jackson L, Varrias D, Michelhaugh S, Januzzi J, Shahideh B . MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure. ESC Heart Fail. 2024; 11(3):1400-1410. PMC: 11098646. DOI: 10.1002/ehf2.14649. View

2.
Yeri A, Courtright A, Danielson K, Hutchins E, Alsop E, Carlson E . Evaluation of commercially available small RNASeq library preparation kits using low input RNA. BMC Genomics. 2018; 19(1):331. PMC: 5936030. DOI: 10.1186/s12864-018-4726-6. View

3.
Daubert M, Adams K, Yow E, Barnhart H, Douglas P, Rimmer S . NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF. JACC Heart Fail. 2019; 7(2):158-168. DOI: 10.1016/j.jchf.2018.10.014. View

4.
Kuosmanen S, Hartikainen J, Hippelainen M, Kokki H, Levonen A, Tavi P . MicroRNA profiling of pericardial fluid samples from patients with heart failure. PLoS One. 2015; 10(3):e0119646. PMC: 4357463. DOI: 10.1371/journal.pone.0119646. View

5.
Shah R, Januzzi Jr J . Soluble ST2 and galectin-3 in heart failure. Clin Lab Med. 2014; 34(1):87-97, vi-vii. DOI: 10.1016/j.cll.2013.11.009. View